Izotropic Corporation (IZO.CN)
Izotropic Corporation operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Surrey, BC, CA. The stock last traded at $0.23, down 6.12% on the session, giving a market capitalisation of $15.9M. Its beta of 2.42 implies it has historically moved more than the broad market.
Izotropic Corporation operates as a MedTech enterprise, concentrating on the commercialization of diagnostic solutions for breast cancer. Their primary focus lies in developing and offering a breast CT imaging system alongside a 3D CT breast imaging platform, both specifically designed to enable earlier detection and more accurate diagnosis of the disease. Established in 2016, the company maintains its corporate base in Surrey, Canada.
Izotropic Corporation is most often compared with the following Healthcare names: